Category: Kintara

  • Kintara Therapeutics restructures share designations By Investing.com

    In a recent move, Kentara Therapeutics, a San Diego, California-based pharmaceutical company, has officially withdrawn its designation of two types of preferred stock. The company, listed on the Nasdaq Capital Market under the symbol KTRA, filed the necessary documents with the Nevada Secretary of State on Friday, July 12, 2024.…